• Members: Login
  • Join
  • Contact
  • Shopping Cart Shopping Cart
    0Shopping Cart
Medical Affairs Professional Society
  • Membership
    • Join MAPS
    • Access your Member Profile
    • Membership FAQ
  • Professional Development
    • Online Courses
    • Knowledge Center
      • Standards & Guidance
      • Position Papers
      • White Papers
      • Benchmark Reports
      • Webinars
      • Elevate Articles
      • Elevate Podcasts
      • Innovate Articles
    • Employee Training Program
    • Textbook
  • MasterClass
    • MasterClass
      • Insights MasterClass: Zurich
      • Integrated Medical Communications MasterClass: Zurich
      • Launch Excellence MasterClass: Zurich
    • MasterClass Onsite
  • Partnerships
    • Industry Partnership Program
    • Partner Circle Program
    • MAPS Media Planner
  • Meetings & Events
    • What are MAPS Meetings?
    • 2026 EMEA Annual Meeting
    • 2026 Japan Summit
    • Webinars
    • Chapters
  • Opportunities
    • Chapters
    • Mentorship
    • Get Involved
  • About
    • Mission, Vision & Value
    • Leadership
    • Career Resources
    • Blog
    • Our Team
    • Policies
    • Bylaws
  • Menu Menu
  • Link to LinkedIn
  • Link to X
  • Link to Instagram

Fatima Ahmad

January 26, 2021/in Executive Program Committee MedComm, Rare Disease/gene Therapy/by Medical Affairs

Fatima Ahmad, PharmD is Vice President of Medical Affairs at Castle Creek Biosciences, a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options.  Previously, she held positions at Spark Therapeutics, a member of the Roche group, including heading the Medical Communications team responsible for leading integrated Medical Communications Strategies across therapeutic areas in Spark’s portfolio of AAV-based investigational gene therapies, as well as serving as Therapeutic Area Leader for hematology. Previously, Fatima spent time at Advaxis Immunotherapies as Senior Director Medical Affairs and at Otsuka Pharmaceuticals, where she held roles of increasing seniority in US and Global Medical Affairs.

Fatima began her industry career at AstraZeneca where she was a Pharmacy intern and subsequently held roles in Medical Information and Medical Communication Science, working across several therapeutic areas including respiratory and oncology. She graduated Magna Cum Laude from Temple University with a PharmD degree, and practiced community pharmacy briefly before transitioning to the pharmaceutical industry. Fatima is passionate about incorporating a patient-centric approach to all aspects of Medical Affairs and is committed to the evolution of Medical Affairs in best serving patients in the era of personalized medicine and novel therapeutic modalities.

 

 

https://medicalaffairs.org/wp-content/uploads/2022/08/Ahmad_Fatima-e1721317871920.png 472 546 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2021-01-26 19:41:072024-09-24 12:43:15Fatima Ahmad

Wilson Joe

April 7, 2026/in Zurich IMC 26/by Jalene Kaiser
https://medicalaffairs.org/wp-content/uploads/2026/04/Joe_Wilson.jpeg 421 421 Jalene Kaiser https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Jalene Kaiser2026-04-07 09:47:462026-04-15 09:05:41Wilson Joe

Ann Granger

June 10, 2022/in Executive Program Committee/by
https://medicalaffairs.org/wp-content/uploads/2022/06/Granger_Granger.jpeg 500 500 https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png 2022-06-10 11:32:042024-10-01 11:01:33Ann Granger

Dannis Chang

September 24, 2024/in Med Info/by Jalene Kaiser
https://medicalaffairs.org/wp-content/uploads/2024/09/Chang_-Dannis-2019.jpg 375 375 Jalene Kaiser https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Jalene Kaiser2024-09-24 12:45:482024-11-13 10:46:33Dannis Chang

Dr. Mussa Arvani, MD, MBA

April 11, 2024/in Field Medical/by Jalene Kaiser
https://medicalaffairs.org/wp-content/uploads/2024/04/Mussa-Arvani-e1738942790642.jpg 640 640 Jalene Kaiser https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Jalene Kaiser2024-04-11 09:55:152024-12-18 13:49:12Dr. Mussa Arvani, MD, MBA

John Pracyk

December 22, 2021/in Medical Technology/by Medical Affairs

John Pracyk is an executive medical leader with deep expertise in the safe and effective design, development, and commercialization of medical devices. Clinically trained as a Neurological Surgeon he possesses an uncommon blend of business and medical expertise and is a passionate proponent of value-based care and outcomes-driven, evidence-based practices. Dr. Pracyk is a recognized thought leader and program architect in the development of collaborative healthcare delivery platforms with a proven track record of multidisciplinary program buildouts and care redesign successes. A servant leader who motivates high-performing teams to outpace innovation timelines, exceed expectations, and fuel organizational transformation.

Prior to joining Olympus, Dr. Pracyk held multiple leadership roles of increasing responsibility with DePuy Synthes-Spine, Johnson & Johnson Medical Devices. He began his MedTech career in 2016 as Franchise Medical Director where he fostered meaningful innovation to drive safety and value for patients worldwide. There he delivered deep medical and scientific insights to the R&D and commercial teams for product ideation and development, including conceptual, hands-on evaluation, and clinical research perspectives.

In 2017, Dr. Pracyk was tapped to be medically responsible for J&J’s Global Spine Platform as the Franchise Medical Leader leveraging integrated procedural solutions to drive innovation and answer unmet clinical needs. He forged relationships with internal and external stakeholders, including Key Opinion Leaders, practicing surgeons, global regulatory agencies, professional societies, and executive leadership teams from hospitals, health systems, and integrated delivery networks.

In 2018, Dr. Pracyk was appointed Integrated Leader of Preclinical Research, Clinical Research, and Medical Affairs (PCM), a newly integrated scientific platform for Spine. The PCM concept incorporates product development with preclinical and clinical research outcomes and unifies them within the context of Medical Affairs to substantiate safety, performance, and value. Their objective is to ensure that all platform decisions are medically informed, surgically literate, clinically relevant, and financially sustainable. His PCM team’s accomplishments were spotlighted in J&J’s Meet the Innovator series as they got out in front of all goals, condensed timetables to move ahead, and completed the clinical post market clinical follow up plans for the new European Medical Device Regulation a full year ahead of schedule.

Outside of Olympus, Dr. Pracyk is becoming a leading voice in the Medical Affairs Professional Society (MAPS) where he was elected President of the Americas Region, Treasurer of the Executive Committee, and Board Director. MAPS amplifies the individual voices of over 6100 medical professionals that serve patients from within 200+ medical device and pharmaceutical manufacturers. By contextualizing the real-world clinical needs of patients, providers, and policy makers MAPS succinctly translates science into value to deliver a strategically critical scientific perspective in today’s ever-changing global healthcare landscape.

Dr. Pracyk obtained his BS, MD and PhD degrees through the Early Identification and the Medical Scientist Training Programs at Duke University. He was competitively awarded research fellowships at Cambridge University and the National Institutes of Health. He received his Neurological Surgery training at Duke University & The George Washington University and then completed a clinical spine fellowship at the University of Iowa. In 2015, he obtained a healthcare focused MBA at the Haslam College of Business of The University of Tennessee. Dr. Pracyk is a Fellow of the American Association of Neurological Surgeons and the American College of Surgeons, as well as a Diplomate of the American Board of Neurological Surgery. He maintains active memberships in the Medical Affairs Professional Society, American Association of Neurological Surgeons, Congress of Neurological Surgeons, North American Spine Society, AO Spine, Phi Kappa Phi, and the American College of Healthcare Executives.

https://medicalaffairs.org/wp-content/uploads/2023/04/P1180082a1-e1741204514635.jpg 1707 1706 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2021-12-22 09:51:472025-04-23 09:26:14John Pracyk

Gregory Christopherson

May 1, 2020/in Membership Committee, Mentorship Working Group Medical Technology Chicago, Launch Excellence Masterclass/by Medical Affairs

Greg Christopherson is the Vice President of Medical Affairs for Medline Industries, a privately-owned manufacturer and distributor of medical devices and supplies devoted to the continuum of healthcare. His current role oversees creation and execution of a comprehensive clinical strategy for the company, encompassing: identification of business and regulatory needs (Clinical Affairs), study design and execution (Clinical Operations), communication of clinical results and publication tactics (Medical Communications) and development of clinical research partners, medical education initiatives and coordination of Medical Science Liaisons (Clinical Development).

Prior to joining Medline, Greg served in a scientific affairs capacity for the medical aesthetics division of Allergan, coordinating R&D efforts to commercially support new product launches and the existing device portfolio for breast implants and acellular dermal matrices. He played a key collaborative role internally, integrating divisions across the company (Regulatory, Sales & Marketing, Medical Affairs, R&D) to define and execute research strategy, as well as acting as the primary scientist for KOL engagement and medical education.

His previous experience is heavily centered in R&D, as a postdoctoral fellow in the NIH examining the pathophysiology of heterotopic ossification in blast-injured soldiers at Walter Reed, and as a senior scientist at LifeCell, creating novel tissue-based devices for colorectal and wound healing applications. He received his B.S. in Biomedical Engineering from Michigan Technological University, and his M.S. and Ph.D. in Materials Science & Engineering from Johns Hopkins University.

https://medicalaffairs.org/wp-content/uploads/2021/11/Christopherson_Greg_photo_052020-e1588682221362.jpg 1198 1200 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2020-05-01 17:57:222025-04-23 08:28:24Gregory Christopherson
David Kelaher

David Kelaher

May 17, 2024/in LE Basel/by Jalene Kaiser
https://medicalaffairs.org/wp-content/uploads/2023/05/Kelaher_David_photo_300x300_051025.jpg 300 300 Jalene Kaiser https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Jalene Kaiser2024-05-17 08:29:362024-07-11 13:18:16David Kelaher

Elise Blankenship

December 28, 2021/in acknowledgements, MedComm/by
https://medicalaffairs.org/wp-content/uploads/2022/07/elise.jpg 800 800 https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png 2021-12-28 10:38:262024-07-31 12:46:20Elise Blankenship
Ivan Desviat

Ivan Desviat

December 21, 2021/in Executive Program Committee External Education/by Medical Affairs

Ivan Desviat, MBA, CHCP is Director Medical Education Excellence for AbbVie biotech overseeing company led Medical Education strategic planning, implementation approach, and program impact measures for Medical Affairs across all company’s Therapeutic Areas at Global HQ and affiliates. He brings more than 20 years of documented success across a variety of Affiliate, EU Regional, US and Global assignments in Medical Affairs organization, Commercial teams and Continuous Performance roles.  

Ivan is recognized for enhancing Medical Affairs internal capabilities such as scientific platforms, KOL engagement, insights, internal training and delivering educational engagement strategies with innovative programs in different local, regional, and global roles.  

He has author several congresses oral, and posters related to medical education research and was granted in 2017 the prestigious GAME Medical Education international award for a PI program in collaboration with the health agency in Spain.  

He recently accepted the role of Co-Chair of the MAPS External Education Focus Area Working Group. In this effort he will be working to enhance the value of Medical Affairs education within the industry while providing visibility to new approaches and solutions recently created in response to the changing landscape.   

Ivan received the bachelor’s degree in industrial chemistry (M.Sc.) from the Universidad Complutense of Madrid (Spain), and was recipient of an Erasmus study grant to complete the Chemical Engineering degree (ChE) from the Ecole européenne de Chimie, Polymères et Materieu at Strasburg (France). He completed his MBA at Instituto de Empresa (IE), and holds a six sigma black belt and CHCP certification.

https://medicalaffairs.org/wp-content/uploads/2021/12/Ivan.Desviat.300x300.jpg 300 300 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2021-12-21 08:48:072023-01-25 12:28:49Ivan Desviat
Page 18 of 84«‹1617181920›»
Search Search
MAPS LinkedIn

Elevate Podcast Channel

Popular
  • Why Good Science is Good Business: A Conversation with Murali...October 15, 2020 - 12:05 PM
  • Journal Selection: Looking Beyond Traditional MetricsJuly 2, 2024 - 9:02 AM
  • Interview: The Value of Medical AffairsJune 10, 2020 - 8:56 PM
  • Learning Agility: An Emergent Capability for Future-Proofing...June 18, 2020 - 3:57 AM
  • Company-Led Education…What is in the Name?September 16, 2020 - 8:17 AM
  • Contemporary Applications of Real-World Evidence in Regulatory...October 20, 2020 - 10:32 AM

Connect with Us

602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073

© 2026 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.

Follow Us
  • Link to X
  • Link to LinkedIn
  • Link to Instagram
Subscribe to MAPS Newsletter
MAPS Program Support Services
Policies and Positions
Scroll to top Scroll to top Scroll to top
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}